title: Angle closure and angle-closure glaucoma: what we are doing now and what we will be doing in the future.
abstract: Primary angle-closure glaucoma (PACG) frequently leads to severe vision loss. Prevalence among older Asian populations is high and given global demographics, the number of persons with PACG will increase dramatically in the coming decades. Improvements in imaging of the anterior segment will help us to identify more of those with angle closure, and important clinical trials that are currently underway will provide important evidence to support screening and treatment approaches for PACG. In this manuscript, we intend to review the existing evidences, to introduce some important on-going studies on PACG and to share the experience and viewpoints of the authors.
authors.affiliation: Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
authors.forename: David S
authors.initials: DS
authors.lastname: Friedman
authors.forename: Paul J
authors.initials: PJ
authors.lastname: Foster
authors.forename: Tin
authors.initials: T
authors.lastname: Aung
authors.forename: Mingguang
authors.initials: M
authors.lastname: He
mesh_terms: D000869:Anterior Eye Segment / Q000473:pathology*; D002986:Clinical Trials as Topic; D015812:Glaucoma, Angle-Closure / Q000175:diagnosis*; D006801:Humans